Clinical trial
Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients
NCT05843786 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- June 30, 2023
- Completion date
- July 30, 2027
- Enrollment
- 132 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.